Pathogenic Study of Adult Immune Enteropathies
NCT04280510 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-09-18
Summary
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
Conditions
- Celiac Disease
- Autoimmune Enteropathy
- Inflammatory Bowel Diseases
Interventions
- GENETIC
-
Blood sample collection; gastrointestinal biopsy
Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...
Sponsors & Collaborators
-
Imagine Institute
collaborator OTHER -
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
Georgia MALAMUT, MD, PhD · APHP, Université de Paris (Université Paris Descartes)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-27
- Primary Completion
- 2030-02-27
- Completion
- 2033-02-27
Countries
- France
Study Locations
More Related Trials
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
NCT07300553 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
NCT02502552 ·Status: COMPLETED
-
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
NCT03359642 ·Status: COMPLETED ·Phase: NA
-
Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease
NCT00780949 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
NCT04997733 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
CD Patients Immune Status Evaluation
NCT04135482 ·Status: COMPLETED
-
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
NCT03370601 ·Status: TERMINATED ·Phase: NA
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
NCT02770495 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease
NCT00561548 ·Status: TERMINATED ·Phase: NA
-
Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences
NCT02883296 ·Status: COMPLETED ·Phase: NA
-
Preclinical Evaluation of Multimodal Therapeutic Strategies in Intestinal Irradiation and Inflammatory Bowel Disease From Organoids
NCT05425901 ·Status: COMPLETED ·Phase: NA
-
Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment
NCT04859829 ·Status: TERMINATED
-
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
NCT05014555 ·Status: UNKNOWN
-
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
NCT00207688 ·Status: COMPLETED
-
Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
NCT00055536 ·Status: COMPLETED ·Phase: PHASE2
-
Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort
NCT02503514 ·Status: COMPLETED
-
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
NCT04973423 ·Status: RECRUITING ·Phase: NA
-
Evolution and Treatments of Chronic Inflammatory Systemic Diseases
NCT04191395 ·Status: RECRUITING
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Host-microbiota-environment Interactions
NCT05176795 ·Status: TERMINATED